BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Vetter To Expand Its Secondary Packaging Service Capacity As A Response To Rising Customer Needs

  Vetter, a global leader in prefilled drug-delivery systems and an expert in complex packaging projects, today announced a major expansion of its secondary packaging capacities as a response to rising customer needs and market demands for complex packaging solutions.

  October 19, 2017

   · 

  3 min read
• 

  Drug Development

  FDA Grants Pluristem Orphan Drug Designation for Its PLX-R18 Cell Therapy as Treatment for Acute Radiation Syndrome

  Pluristem’s ARS program is developed and funded by the U.S. National Institutes of Health and the U.S. Department of Defense, and is in preparation for a pivotal study.

  October 19, 2017

   · 

  5 min read
• BioMidwest

  Myriad’s GeneSight Shown to Statistically Significantly Improve Generalized Anxiety Disorder Treatment Response and Decrease Benzodiazepine Use

  The positive results were presented at the 25th World Congress of Psychiatric Genetics.

  October 19, 2017

   · 

  8 min read
• Drug Development

  Corbus Pharmaceuticals Reports Positive Topline Results From Phase 2 Study In Rare Autoimmune Disease Dermatomyositis

  Corbus Pharmaceuticals Holdings announced positive topline results from its 16-week Phase II study of safety and efficacy of anabasum in dermatomyositis (“DM”).

  October 19, 2017

   · 

  8 min read
• Business

  INSYS Therapeutics to Report Third Quarter 2017 Results on Nov. 2

  The third quarter 2017 financial results will release on Thursday, Nov. 2, before the U.S. financial markets open.

  October 19, 2017

   · 

  1 min read
• Biotech Bay

  Science Exchange Honored by Goldman Sachs for Entrepreneurship

  Goldman Sachs is recognizing Elizabeth Iorns, Ph.D., co-founder and CEO of Science Exchange as one of the 100 Most Intriguing Entrepreneurs of 2017 at its Builders & Innovators Summit in Santa Barbara, California.

  October 19, 2017

   · 

  3 min read
• Business

  3D Signatures Announces Changes to Its Board of Directors and Audit Committee

  3D Signatures added Keith Cassidy to the Company’s board of directors and to the Company’s audit committee, effective immediately.

  October 19, 2017

   · 

  5 min read
• IDBS Takes Bioanalysis Informatics To The Cloud

  Today IDBS has announced the release of its next-generation bioanalytical informatics solution.

  October 19, 2017

   · 

  2 min read
• Business

  Emergent BioSolutions to Release Third Quarter and Nine Months 2017 Financial Results and Conduct a Conference Call on November 2, 2017

  The company will also host a conference call at 5:00 pm (Eastern Time) at which time members of management will discuss these results.

  October 19, 2017

   · 

  1 min read
• Drug Development

  BerGenBio Announces Start Of Phase II Trial Assessing Selective AXL Inhibitor BGB324 In Combination With KEYTRUDA For Patients With Advanced Breast Cancer

  BerGenBio announces that the first patient has been dosed in a Phase II trial evaluating the Company’s lead product BGB324 in combination with KEYTRUDA (pembrolizumab).

  October 19, 2017

   · 

  4 min read